Divestments and regulatory action impact Sanofi

5 August 2019 - Deborah Wilkes

Premium

Sanofi's Consumer Healthcare business reported worldwide sales up by 1.1% at constant exchange rates in the second quarter of 2019. The company said brand divestments and tightening regulatory requirements, particularly in Europe, had reduced growth by around two percentage points.

Click tags below for more information on topics:

Sanofi Consumer Healthcare ANSM

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: